Charles River Laboratories International Inc (CRL)

408.13 -8.18  -1.96% NYSE Aug 5, 10:36 USD
View Full Chart
Price Chart
View All CRL News

News

View All Events

Events

Date Type Description
10/29/2021 Earnings Results Q3 2021 Earnings Results
10/29/2021 09:30 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 09:30 EST Earnings Calls Q2 2021 Earnings Call
05/06/2021 08:00 EST AGM 2020 Annual General Meeting
05/04/2021 Earnings Results Q1 2021 Earnings Results
05/04/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
02/17/2021 Earnings Results Q4 2020 Earnings Results
02/17/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
  • URL: https://www.criver.com
  • Investor Relations URL: https://ir.criver.com
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Oct. 29, 2021
  • Last Earnings Release: Aug. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
FID5045 Fidelity Small Cap America Series E5 (USD) 5.27%
FBT First Trust NYSE Arca Biotech ETF 3.45%
FSMEX Fidelity® Select Medical Tech and Devcs 2.92%
EBCGX MFS Mid Cap Growth 529B 2.41%
BMRRX BlackRock Mid-Cap Growth Equity R 2.35%
RPG Invesco S&P 500® Pure Growth ETF 1.60%
IBB iShares Biotechnology ETF 1.50%
VISGX Vanguard Small Cap Growth Index Inv 0.78%
VBK Vanguard Small-Cap Growth ETF 0.78%
SCHM Schwab US Mid-Cap ETF™ 0.46%
NAESX Vanguard Small Cap Index Inv 0.34%
VB Vanguard Small-Cap ETF 0.34%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.